drugset / Trial / NCT07383103
Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of the combination therapy of hydrocortisone and fludrocortisone among adult patients with septic shock.
Timeline
- Start
- 2026-03-02
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fludrocortisone | Other / unclassified | 50 ug | Oral |
| Subject | Hydrocortisone | Other / unclassified | 200 mg | Intravenous |